**Question:** Gold standard method of diagnosing celiac disease is

A. Serological tests (e.g., anti-tissue transglutaminase antibodies)
B. Endoscopy with biopsy
C. Radiological studies (e.g., small bowel follow-through, capsule endoscopy)
D. Genetic testing

**Correct Answer: B. Endoscopy with biopsy**

**Core Concept:** Celiac disease is an autoimmune disorder characterized by the destruction of small intestinal villi due to the immune response to gluten consumption in genetically susceptible individuals. The gold standard method for diagnosing celiac disease involves assessing both serological markers and visualizing the small intestine to confirm villous atrophy, which is a key pathological feature of the disease.

**Why the Correct Answer is Right:** Endoscopy with biopsy is the gold standard for diagnosing celiac disease because it allows direct visualization of the small intestine, specifically the mucosal surface, and biopsy sampling. This combination provides evidence of villous atrophy, which is a definitive pathological indicator of celiac disease, despite the presence of specific serological markers like anti-tissue transglutaminase antibodies (option A). Biopsy sampling also allows for the assessment of the small intestine's inflammation, crypt hyperplasia, and intraepithelial lymphocyte count, which are crucial for confirming the diagnosis of celiac disease.

**Why Each Wrong Option is Incorrect:**

**Option C (Radiological studies):** While radiological studies like small bowel follow-through and capsule endoscopy can provide indirect evidence of celiac disease, they lack the ability to confirm the key pathological feature of villous atrophy seen in endoscopy with biopsy. Inaccuracies in these tests can lead to false positives or negatives, therefore making endoscopy with biopsy more reliable.

**Option D (Genetic testing):** Although genetic testing can identify patients with celiac disease who have a specific HLA genotype, it is not a diagnostic tool for the disease. Genetic testing can only confirm the presence of genetic susceptibility and is not sufficient for making a definite diagnosis of celiac disease.

**Option A (Serological tests):** Serological tests, such as anti-tissue transglutaminase antibodies, help identify patients with celiac disease but are not sufficient for diagnosis. The presence of these antibodies does not guarantee the presence of celiac disease, and endoscopy with biopsy is required to confirm the diagnosis.

**Clinical Pearl:** A comprehensive evaluation for celiac disease involves serological testing and endoscopy with biopsy, as the combination of these methods provides a definitive diagnosis. However, the biopsy sample is crucial to confirm villous atrophy and other pathological features of celiac disease, while serological tests are used for screening and identifying patients for further evaluation.